Mountain Crest SPAC Archives - Medical Design Sourcing

Better Therapeutics closes SPAC merger, debuts on Nasdaq

Better Therapeutics announced today that it completed its merger with Mountain Crest Acquisition Corp and has gone public on the Nasdaq.

San Francisco-based Better Therapeutics announced its intention to merge with Mountain Crest, a publicly-traded, special purpose acquisition corporation (SPAC), in April. Last month, the company confirmed its expectations for the $113 million SPAC merger to go through by the end of October, as it has today.

Get the full story at our sister site, Drug Delivery Business News.

Better Therapeutics expects $113M SPAC merger to go through in October

Better Therapeutics announced today that it expects its merger with Mountain Crest Acquisition Corp to close next month.

San Francisco-based Better Therapeutics announced its intention to merge with Mountain Crest, a publicly-traded, special purpose acquisition corporation (SPAC), in April. At the time of the announcement, the companies expected the merger to be completed some time in the summer of 2021.

Get the full story at our sister site, Drug Delivery Business News.

Better Therapeutics to go public via $113M merger with SPAC

Better Therapeutics announced today that, through a $113 million merger with Mountain Crest Acquisition Corp II, it will go public.

Mountain Crest, a publicly-traded, special purpose acquisition corporation (SPAC), will acquire Better Therapeutics in a deal expected to be completed in the summer of this year, with the company continuing to operate as Better Therapeutics while being listed on the Nasdaq under the BTTX ticker, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.